Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Harrell currently holds 2,090,750 shares of OptimizeRx Corp (OPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Harrell has been a net seller of OPRX stock. They have purchased $0 and sold $1.4M worth of shares.
David Harrell's most recent insider trade was on Jun 1, 2017, when they sold 500,000 shares at $0.78 per share.
David Harrell serves as Executive at OptimizeRx Corp (OPRX). They have executed 9 insider transactions totaling $1.4M over their tenure at the company.
David Harrell holds the position of Executive at OptimizeRx Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
David Harrell has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Harrell was on Apr 24, 2014, when they sold $884.0K worth of OPRX shares. This transaction involved 552,500 shares at $1.60 per share.
David Harrell currently owns 2,090,750 shares of OptimizeRx Corp (OPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Harrell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Harrell has 9 Form 4 filings on record as an insider at OptimizeRx Corp.
Set alerts for David Harrell and 40,000+ other insiders.